Long-term Study Results Show That PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

0
1395

Final results from the RESPECT study reported at TCT 2016

Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occulder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke. The U.S. Food and Drug Administration (FDA) recently approved the device for recurrent stroke prevention in patients with a PFO and history of cryptogenic stroke on the basis of these data. A PFO is a small hole between the atria that did not close completely early in life and which can allow a venous system clot to enter the left atrium and travel to the brain causing a stroke. Current guidelines call for a medical management with anticoagulants or antiplatelet drugs for patients with PFO following a cryptogenic stroke. 

o

Click here to read more.

Print Friendly, PDF & Email
o